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Abstract
Acute or chronic non-neoplastic diffuse mediastinal diseases have multiple causes, degrees of severity, and a wide
range of management. Some situations require emergency care while others do not need specific treatment.
Although the diagnosis may be suspected on chest X-ray, it is mainly based on CT. A delayed recognition is not
uncommonly observed. Some findings may prompt the radiologist to look for specific associated injuries or lesions.
This pictorial review will successively describe the various non-neoplastic causes of diffuse mediastinal diseases with
their typical findings and major differentials.
First, pneumomediastinum that can be provoked by extra- or intra-thoracic triggers requires the knowledge of
patient’s history or recent occurrences. Absence of any usual etiological factor should raise suspicion of cocaine
inhalation in young individuals.
Next, acute mediastinitis may be related to post-operative complications, esophageal perforation, or contiguous
spread of odontogenic or retropharyngeal infections. The former diagnosis is not an easy task in the early stage,
owing to the similarities of imaging findings with those of normal post-operative appearance during the first 2–3
weeks.
Finally, fibrosing mediastinitis that is linked to an excessive fibrotic reaction in the mediastinum with variable
compromise of mediastinal structures, in particular vascular and airway ones. Differential diagnosis includes tumoral
and inflammatory infiltrations of the mediastinum.
Keywords: Diffuse mediastinal diseases, Mediastinum, Pneumomediastinum, Acute mediastinitis, Fibrosing
mediastinitis and mimickers
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Key points
 Pneumomediastinum requires exclusion of
tracheobronchial injury.
 Mediastinal post-operative changes are indistin-
guishable from acute mediastinitis during the first
weeks following surgery.
 CT, 18F-FDG PET/CT, and diffusion-weighted or
dynamic contrast-enhanced MRI may help to nar-
row the differential diagnosis and may guide tissue
sampling.
Background and technical approach
Diffuse mediastinal diseases comprise a heterogeneous
group of entities characterized by various degrees of se-
verity [1]. Although these diseases are well-known disor-
ders, diagnosis is not uncommonly delayed due to
nonspecific and sometimes faint clinical presentations
and symptoms, even in the potentially more serious con-
ditions. Pneumomediastinum should be suspected in
case of chest pain, dyspnea, and subcutaneous emphy-
sema. However, acute mediastinitis commonly presents
with fever, pleuritic or retrosternal chest pain, and in-
flammatory syndrome. In fibrosing mediastinitis, the
main clinical symptoms include dyspnea and superior
vena cava syndrome due to external vascular stricture
and airway stenosis. Careful clinical evaluation and
radiological correlation is of the utmost importance
when approaching diffuse mediastinal pathologies in
order to differentiate neoplastic mediastinal infiltration.
Although mediastinal involvement may be suspected
on chest radiographs, the signs may be easily missed;
hence CT, and, in selected patients, MRI, should be con-
ducted to evaluate the mediastinal compartments. High-
resolution imaging is required to provide a detailed as-
sessment of the mediastinal compartment and its com-
plex anatomy, as well as associated anomalies. CT, with
a water-soluble contrast agent following a non-contrast
acquisition, may demonstrate the esophageal rupture in
case of pneumomediastinum, or stenosis in case of
chronic mediastinitis. Next, an acquisition with IV con-
trast may be beneficial in acute and chronic mediastini-
tis—simultaneous injection of contrast material via
brachial veins on both sides may be considered—because
this can also depict the regional environment, as well as
any additional findings. 18F-FDG PET/CT and diffusion/
dynamic contrast-enhanced MRI [2] may be helpful in
assessing disease extent and guiding tissue sampling.
Fluoroscopy may be part of the diagnosis if an esopha-
geal rupture is suspected and/or in case of vascular com-
promise as part of the therapeutic procedure.
Specific associated injuries or lesions need to be sys-
tematically determined, based on the imaging findings.
Various non-neoplastic conditions will be discussed in
the following sections.
Clinical scenarios
Pneumomediastinum
Pathophysiology
Pneumomediastinum, defined as free gas located within
the mediastinum, may dissect along fascial sheaths (Fig. 1)
to create a cervical and thoracic subcutaneous emphysema
[3]. Pneumorrachis, pneumoperitoneum, or rarely, retro-
pneumoperitoneum, and even air within the esophageal
wall that mimics an esophageal dissection (Fig. 2), may be
observed [4].
The Macklin effect, or pulmonary interstitial emphy-
sema, which is responsible for more than 95% of cases,
corresponds to an alveolar rupture with air dissection
along the interstitial sheaths toward the mediastinum
(Fig. 1), eventually leading to a pneumomediastinum [5].
The Macklin effect, more frequent than esophageal or
tracheobronchial disruptions, has been reported in 39%
of cases of severe, blunt trauma pneumomediastinum. It
Fig. 1 Atraumatic pneumomediastinum. A patient with sudden spontaneous retrosternal and interscapular pain. Frontal chest X-ray (a), coronal
oblique reformation in lung windowing (b), and axial slices (c, d) show gas outlining the mediastinal structures, with pneumopericardium (orange
arrows in a and d) appearing as a left paracardiac subtle line in a and subcutaneous emphysema. Note the right aortic arch. Conservative
management led to a favorable outcome
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has been associated with a significantly prolonged inten-
sive care stay, reflecting severe trauma [3, 5]. Import-
antly, its identification does not rule out a
tracheobronchial injury (Fig. 2), which must be excluded
in cases of traumatic as well as post-procedure pneumo-
mediastinum [4] (Fig. 3).
Iatrogenic causes
At least half of all esophageal perforations are estimated
to be iatrogenic in nature. This can result from endo-
scopic or surgical procedures, as well as thermal injury
during left atrial ablation. Typical imaging findings in-
clude pneumomediastinum, pleural effusion on the left
side more commonly than on the right side, and medias-
tinal hematoma [6] with extravasation of swallowed
water-soluble contrast.
Boerhaave’s syndrome
Spontaneous rupture, known as Boerhaave’s syndrome,
occurs when incomplete crico-pharyngeal relaxation
during vomiting results in a sudden increase in intra-
luminal esophageal pressure (Fig. 4). Rupture is most
common in the distal left posterior wall immediately
above the diaphragm. It may be suspected on a chest X-
ray in patients with esophageal rupture but is not spe-
cific to that condition. Esophageal rupture is
Fig. 2 Traumatic pneumomediastinum. A patient who experienced high-velocity trauma while skiing with subcutaneous emphysema, bilateral
pneumothorax, and pneumomediastinum. Note the air within the esophageal wall that subsequently resolved 1 day later, at the level of the
supra-aortic vessels (a, b) and below the carina (c, d) (orange arrows). This appearance mimics the presence of an intramural esophageal
dissection that mandates the need to exclude an esophageal injury, which was the case here. Repeated bronchoscopy performed due to
persistent air leak through the right drainage tube revealed multi-segmental right bronchial fistulae
Fig. 3 Pneumomediastinum related to tracheo-esophageal injuries. A patient resuscitated after cardiac arrest with pneumomediastinum related
to both tracheal and esophageal injuries. The major finding on the chest X-ray (a) was the subcutaneous emphysema. Conversely, the
pneumomediastinum is perfectly demonstrated on the axial CT scan (b)
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Fig. 4 Boerhaave’s syndrome related to esophageal rupture. a Chest X-ray shows pneumomediastinum with subcutaneous emphysema. b
Naclerio V sign in another patient. In this case, the Naclerio V sign was the only finding that raised the suspicion of an esophageal rupture (not
shown) with a focal and limited pneumomediastinum. c Axial CT scan in lung windowing that shows the pneumomediastinum with bilateral
pleural effusion and alveolar consolidation (d). Iodine hydro-soluble contrast on a lateral view shows extravasation above the diaphragm in front
of the esophagus (Patient (a))
Fig. 5 Infectious mediastinitis. Acute, descending, necrotizing mediastinitis related to an oropharyngeal infection treated with non-steroidal anti-
inflammatory drugs and antibiotics. Latero-pharyngeal (a) and median and right-sided mediastinum are (c) hypodense, with peripheral
enhancement collections in coronal reformatting and bilateral pleural effusion and passive atelectasis (c); pleural effusion with parietal pleural
enhancement related to bilateral empyema and pericardial effusion, and parietal pericardial enhancement related to purulent pericardial effusion
on axial (b) and coronal views (d)
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characterized by a V-shaped air collection, with one limb
of the V produced by mediastinal gas that outlines the
left lower lateral mediastinal border, and the other limb
produced by gas between the parietal pleura and medial
Fig. 6 Post-operative changes versus mediastinitis. Similarities of CT aspects in two different conditions: normal post-operative appearance of the
mediastinum during the first 2–3 weeks after Bentall surgery (a) and mediastinitis (b), both presenting as an increased attenuation of fat. In
addition, the careful analysis of bone and cartilage, which is required in all cases of acute mediastinitis using bone-windowing, is well
demonstrated in these two different cases with cartilage abscess (c) and sternal osteitis (d), respectively
Fig. 7 Post-mediastinitis aneurysm. Fatal, false aneurysm complicating a mediastinitis following an EBUS procedure. EBUS had been performed in the
context of a suspicion of stage IV lung cancer. Contrast-enhanced CT was performed 35 days after EBUS because the patient complained of chest pain.
Successive axial CT images (a–c) show a diffuse infiltration of the mediastinal fat with a false aneurysm (arrow) that developed on the right side of the
aortic arch. Coronal reformation shows the cranio-caudal extent of the false aneurysm (arrow) (d). A pericardial effusion is present
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left hemidiaphragm. Mortality is high without prompt
thoracotomy [6].
Tracheobronchial lesions
Tracheobronchial lesions are rare, occurring in 1 to
3% of patients with blunt trauma and 2 to 9% of
those who suffer penetrating cervical and/or thor-
acic injuries. The former preferentially causes le-
sions in the intra-thoracic trachea and main-stem
bronchus, 80% of which are up to 2.5 cm from the
carina, most commonly on the right side, and are
considered less protected by the mediastinal struc-
tures. Uncommon causes include iatrogenic injuries,
such as intubation-related trauma [7] (Fig. 3).
Other conditions
Other causes of pneumomediastinum include acute
exacerbation of severe asthma, excessive coughing, dia-
betic ketoacidosis, physical exertion, the Valsalva man-
euver, or inhalational drug abuse [5], as well as extra-
thoracic causes, such as facial fracture. In young indi-
viduals, the absence of other etiological factors should
raise the suspicion of free-base cocaine use [8]. Rare
circumstances, such as a lightning strike or insufflation
of the content of a dry chemical fire extinguisher, have
also been reported.
Acute mediastinitis
Pathophysiology
Most cases of acute mediastinitis are encountered
following cardiovascular or other thoracic surgical
procedures. Risk factors for post-sternotomy med-
iastinitis may be categorized into patient-related, in-
cluding age as well as co-morbidities, such as
obesity, diabetes, history of smoking, COPD, and
renal failure, and operative factors or environmental
elements (operating room and medical devices) [9].
Other cau ses typically comprise either esophageal
perforation or the contiguous spread of odontogenic
or retropharyngeal infections (Fig. 5). Rarely, mediasti-
nitis may result from a penetrating trauma or
hematogenous spread of infection.
Imaging findings
In a retrospective study that included 40 various
causes of acute mediastinitis, the most common ab-
normal findings were represented by increased attenu-
ation of fat and pleural effusion, followed by free gas
bubbles in the mediastinum, localized mediastinal fluid
collections, sternal dehiscence, mediastinal lymph
nodes, pericardial effusion, lung infiltrates, and pleuro-
mediastinal fistula [10]. There was a high sensitivity
and specificity for CT after day 17 in post-operative
patients, with a low diagnostic yield in the early post-Ta
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operative period. The normal post-operative appearance
of the mediastinum during the first 2–3 weeks after sur-
gery may mimic mediastinitis (Fig. 6) and may not re-
turn to normal for as long as 2months after surgery.
This lack of specificity of CT during the first 2 weeks
requires a careful correlation between clinical and radio-
logical findings that require contrast-enhanced CT.
In any case, careful analysis of cartilage and bone is
necessary to detect loco-regional involvement, such as a
cartilaginous abscess or focal osteitis (Fig. 6).
Fig. 8 Post-mediastinitis pulmonary hypertension. Pulmonary artery stenosis in a case of fibrosing mediastinitis with pulmonary hypertension.
Contrast-enhanced CT scan demonstrated at two successive levels (a, b), with a soft tissue attenuation mass diffusely infiltrating the mediastinum
with encasement and narrowing of the pulmonary arteries (arrows). The stenosis of the right pulmonary artery is perfectly observed on the
oblique 3D rendering view (c) (arrow). This mass had no significant metabolic uptake on 18F-FDG PET/CT (not shown). Note also the stenosed
upper pulmonary veins
Fig. 9 Post-mediastinitis venous complication. A patient with sclerosing mediastinitis. In addition to the encasement of the pulmonary artery,
there was a narrowing of the pulmonary veins, well assessed on the successive CT slices (a, b), as well as on the oblique reformation (orange
arrows) (c) and 3D view (blue arrows) (d). Diagnosis was delayed due to confounding factors related to a history of pulmonary embolism with
pulmonary hypertension and tuberculosis
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Complications
Fatal aortic arch ruptures (Fig. 7) have been reported in
the context of mediastinitis that originated from several
conditions, including odontogenic infection, foreign
body ingestion, endoscopic botulinum toxin injection, or
after open heart surgery [11].
Fibrosing mediastinitis and mimickers (Table 1)
Pathophysiology
Fibrosing mediastinitis (FM), also known as sclerosing
mediastinitis, is a condition related to an abnormal
immunologic reaction that results in the proliferation
of fibro-inflammatory tissue in the mediastinum and/
or hila [12]. It leads to a variable constriction of sys-
temic veins, pulmonary arteries and veins, the airways
and/or the esophagus, with a morbidity related to lo-
cation and extent of fibrosis. The pleura, pericardium, and
coronary arteries may also be involved [12].
Granulomatous subtype
The most common form is the focal or granuloma-
tous subtype of fibrosing mediastinitis, mainly due to
histoplasmosis (less frequently tuberculosis), and other
fungal or inflammatory conditions, such as sarcoid-
osis. This form usually manifests as a localized, calci-
fied mass in the paratracheal or subcarinal regions of
the mediastinum or in the pulmonary hila, commonly
responsible for a superior vena cava syndrome. Diag-
nosis can be made based on imaging findings, pre-
venting the need for tissue sampling.
Non-granulomatous subtype
The diffuse or non-granulomatous subtype accounts for
about 10 to 20% of cases of fibrosing mediastinitis. It
may be idiopathic or can originate in association with
autoimmune disorders, methysergide exposure, or prior
radiation exposure [12]. Fibrosing processes in other lo-
cations, such as retroperitoneal fibrosis, may also be en-
countered [12]. This subtype, which affects multiple
mediastinal compartments and which is sometimes di-
agnosed after considerable delay, manifests as diffusely
infiltrated soft tissue, rarely calcified, with heteroge-
neous enhancement after intravenous administration
of contrast material. Each structure can be sur-
rounded, encased, and/or occluded. It is noteworthy
that a sequential occurrence is observed in this set-
ting, with a primary involvement of the pulmonary
veins, then the pulmonary arteries, and finally the air-
ways. While extrinsic compression of the pulmonary
arteries and/or veins is a major cause of pulmonary
hypertension (Figs. 8 and 9), longstanding pulmonary
venous occlusion may also lead to secondary pulmon-
ary arterial hypertension and cor pulmonale. In
addition, arterial and venous compression may lead to
an imaging appearance of unilateral pulmonary edema
(Fig. 10) [13], and hemoptysis may occur due to
hypertrophy of the systemic arteries. With regard to
airway involvement, the trachea and the main, lobar,
and/or segmental bronchi may be involved and are
characterized by volume loss, chronic post-obstructive
pneumonitis, endoluminal mucus plugs, or
Fig. 10 Post-tuberculous mediastinitis. A patient with chronic mediastinitis related to sequelae after tuberculosis. Axial (a) and coronal (b) CT in
mediastinal windows show infiltration of the mediastinum and hila, which led to narrowing of the pulmonary veins on the right side. CT scan at
the level of the heart in pulmonary windows shows right-sided septal-line thickening linked to impaired venous return (thanks to Prof. Halimi,
Georges Pompidou Hospital, France)
Fig. 11 IgG4-related mediastinitis. A patient with fibrosing mediastinitis as an unusual mediastinal manifestation of IgG4-related disease. Three
successive axial slices (a–c) show diffuse infiltration of the mediastinum with collaterals due to occlusion of the systemic veins
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bronchiectasis [12]. Although surgical biopsies are
more appropriate, the role of percutaneous CT-guided
core tissue biopsies should be emphasized.
IgG-4 related disease
Fibrosing mediastinitis has been reported as an un-
usual mediastinal manifestation of IgG4-related
Fig. 12 Erdheim-Chester disease. Typical pattern of Erdheim-Chester disease with infiltration of the right coronary artery sulcus (a) and the
pericardium, well assessed on a sagittal reformation (b). In addition to the mediastinal/pericardial involvement encasing the right pulmonary
artery, note the right paravertebral thickening on axial slices (a, c). Renal involvement with infiltration of the sinuses was also observed (d)
Fig. 13 Hodgkin’s lymphoma. Diffuse mediastinal involvement well demonstrated on a coronal (a) and two successive axial slices (a, b). There is
a contiguous pericardial involvement (c), with increased metabolic activity on the 18F-FDG PET-CT (d) (arrow). Note also the increased metabolic
activity of the D11 vertebrae, suspicious for bone involvement (arrowhead), the partial resolution of the left pleural effusion following drainage, as
well as a new right pleural effusion
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disease (Fig. 11) [14]. The diagnosis requires a com-
prehensive evaluation for other disease manifestations,
including Riedel’s thyroiditis, retroperitoneal fibrosis,
sclerosing cholangitis, or autoimmune pancreatitis
[12], which may precede and/or suggest the diagnosis.
Improvement with corticosteroid therapy has been de-
scribed in this setting in contrast to numerous other
forms of fibrosing mediastinitis.
Erdheim-Chester disease
In addition to IgG4 disease, some disorders, such as
Erdheim-Chester disease, must be suspected in case of
multisystemic involvement. This rare, non-inherited,
non-Langerhans form of histiocytosis, commonly with a
BRAF mutation, is characterized by xanthomatous infil-
tration of the involved tissues with foamy histiocytes
surrounded by fibrosis, and appears with heterogeneous
systemic manifestations. A common peri-aortic infiltra-
tion that extends to the pericardium, the right coronary
sulci, and/or the myocardium of the right atrium with
pleural involvement may point toward this rare entity.
Furthermore, bone, renal, and retroperitoneal involve-
ment (Fig. 12) [15] have been observed. Cardiac-gated
CT is required to detect coronary involvement.
Differential diagnosis
The radiological differential diagnosis of diffuse fibrosing
mediastinitis is extensive (Fig. 14) [16] and includes
lymphoma (Fig. 13) [11], primary lung cancer, metastases,
Castleman disease, and uncommonly, atypical sarcoidosis
or granulomatosis with polyangiitis. Benign disorders,
such as amyloidosis or lymphangiomatosis, may also dif-
fusely infiltrate into the mediastinum (Fig. 15) [17]. The
latter affects the lymphatic channels from the mediasti-
num to the pleura, with an associated thickening of the
pulmonary peribronchovascular bundles and interlobular
septae, reflecting the lymphatic distribution. Infectious
disorders, such as actinomycosis, aspergillosis, zygomyco-
sis, coccidioidomycosis, nocardiosis, mycobacterial infec-
tion, or syphilis, should also be excluded.
Diagnostic work-up
In addition to CT and 18F-FDG PET/CT, diffusion and
dynamic contrast-enhanced MRI sequences may be useful
to ensure an exhaustive assessment of the disease, particu-
larly its cardiovascular extent. Moreover, these sequences
may point out the optimal areas to biopsy (Fig. 14) [18].
Due to the histological complexity of these various en-
tities, cytological sampling with fine-needle aspirations
should be avoided and surgical biopsy sampling is often
Fig. 14 Thymoma. Two cases of diffuse infiltration of the mediastinum from different causes. The first is related to a fibrosing mediastinitis (a),
while the other corresponds to a recurrence of a histologically proven thymoma stage IVA (b), highly metabolic on PET/CT (c). Neither disorder
can be differentiated morphologically
Fig. 15 Pulmonary lymphangiomatosis. A patient with diffuse pulmonary lymphangiomatosis. Such an infiltration that may not be differentiated
from another diffuse, soft tissue mediastinal disease is well assessed on a coronal (a) and an axial (b) slice. Note the associated right pleural
involvement (a–c), with thickening of the pulmonary peribronchovascular bundles and interlobular septae (arrows in c) that reflect
lymphatic distribution
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required to ensure sufficient material for detailed histo-
logic analysis, immunohistochemical staining, molecular
analyses, and culturing [11], if needed (Fig. 15) [12].
In all cases, a systematic analysis of the pulmonary veins
and arteries, as well as the tracheobronchial tree and
esophagus, is advised when encountering any infiltrative
soft tissue density within the mediastinum. This may help
to suggest the diagnosis of chronic mediastinitis and, thus,
avoid delayed recognition of this condition. Such an ap-
proach has to be combined with an overall analysis of the
retroperitoneum, liver, thyroid, and pancreas.
Conclusion
In conclusion, non-malignant diffuse mediastinal disease
presents with various characteristics, depending on the
mechanism involved. The differential diagnosis calls for
a systematic approach that includes the patient’s history
and habits, excludes a tracheobronchial or esophageal
injury in acute conditions, and requires a careful and
precise histological examination in diffuse mediastinal
tissue infiltration.
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